A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada

Somatostatin analogs (SSAs; lanreotide autogel and octreotide long-acting release) are used to treat neuroendocrine tumors; however, factors that influence SSA use are unclear. METHODS: This real-world, observational study collected data from private/public pharmacy claims for patients using SSAs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Winson Y., LaForty, Callahan, Liovas, Anna, McKechnie, Heather, Loree, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144276/
https://www.ncbi.nlm.nih.gov/pubmed/37078938
http://dx.doi.org/10.1097/MPA.0000000000002144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144276/
https://www.ncbi.nlm.nih.gov/pubmed/37078938
http://dx.doi.org/10.1097/MPA.0000000000002144

Ejemplares similares